Drug recall · June 1, 2016
Amikacin Sulfate injection USP recall
Why: Presence of Particulate Matter: particulate matter identified as glass in one vial.
Class I: a reasonable chance the product could cause serious harm or death.
The recall
- Product
Amikacin Sulfate injection USP,1 gm/4 mL (250 mg/mL) 4mL vial, Rx only, Manufactured in Hungary For: Teva Pharmaceuticals USA, INC. North Wales, PA 19454. Individual Pack NDC 0703-9040-01, Shelf Pack NDC 0703-9040-03
- Lots / codes
Lot #: 4750915, Exp 9/2017
- Quantity
- 6,291 units
- Company
- Teva Pharmaceuticals USA, North Wales, PA
- Distribution
- Nationwide and Puerto Rico
- Initiated
- March 9, 2016 · Voluntary: Firm initiated
- Classified
- May 23, 2016
- Reported
- June 1, 2016
- Ended
- February 7, 2017
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Amikacin
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.